Alkami Technology is rated a strong buy, with a likely 25–30% M&A premium and compelling standalone upside. ALKT boasts 30% revenue growth, 96% subscription revenue, 113% net retention, and a ...

Objective A synthesis and appraisal of the recommendations for biomarkers in practice guidelines concerning sepsis is required to consolidate evidence-based practice. We generated an evidence gap map ...

Historically, facial prosthetics have successfully rehabilitated individuals with acquired or congenital anatomical deficiencies of the face. This history includes extensive efforts in research and ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...